These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 8110915)

  • 21. Comparative neurotransmitter reuptake and anticholinergic potencies of the 8-hydroxy metabolites of clomipramine.
    Núñez R; Perel JM
    Psychopharmacol Bull; 1995; 31(2):217-21. PubMed ID: 7491371
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clomipramine increases firing rate in lateral septal neurons related with hippocampus.
    Marván ML; Contreras CM
    Physiol Behav; 1993 Jul; 54(1):13-8. PubMed ID: 8392207
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Studies on lithium potentiation of antidepressant treatment].
    Okamoto Y; Motohashi N; Hayakawa H; Kikumoto O; Kawai K; Tanra AJ; Nishida A; Yamawaki S
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1994 Feb; 14(1):19-25. PubMed ID: 8048278
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Parenteral clomipramine challenge in depressed adolescents: mood and neuroendocrine response.
    Sallee FR; Vrindavanam NS; Deas-Nesmith D; Odom AM; Carson SW; Sethuraman G
    Biol Psychiatry; 1998 Oct; 44(7):562-7. PubMed ID: 9787880
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serotonergic responsivity in obsessive-compulsive disorder. Effects of chronic clomipramine treatment.
    Zohar J; Insel TR; Zohar-Kadouch RC; Hill JL; Murphy DL
    Arch Gen Psychiatry; 1988 Feb; 45(2):167-72. PubMed ID: 3276283
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The tricyclic antidepressant clomipramine dose-dependently reduces regional cerebral metabolic rates for glucose in awake rats.
    Freo U; Pietrini P; Dam M; Pizzolato G; Battistin L
    Psychopharmacology (Berl); 1993; 113(1):53-9. PubMed ID: 7862829
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lithium increases 5-HT-mediated prolactin release.
    McCance SL; Cohen PR; Cowen PJ
    Psychopharmacology (Berl); 1989; 99(2):276-81. PubMed ID: 2508166
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The mechanisms of action of lithium. I. Effects on serotoninergic and noradrenergic systems in normal subjects.
    Manji HK; Hsiao JK; Risby ED; Oliver J; Rudorfer MV; Potter WZ
    Arch Gen Psychiatry; 1991 Jun; 48(6):505-12. PubMed ID: 1645513
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clomipramine enhances prolactin and growth hormone responses to L-tryptophan.
    Anderson IM; Cowen PJ
    Psychopharmacology (Berl); 1986; 89(1):131-3. PubMed ID: 3016787
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The clomipramine test and subtypes of depression].
    González-Pinto A; López Ibor JJ; Sáiz J; Gutiérrez M; Figuerido JL; García Godoy MJ
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1996; 24(6):303-9. PubMed ID: 9054201
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical efficacy of tandospirone augmentation in patients with major depressive disorder: a randomized controlled trial.
    Yamada K; Yagi G; Kanba S
    Psychiatry Clin Neurosci; 2003 Apr; 57(2):183-7. PubMed ID: 12667165
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clomipramine challenge responses covary with Tridimensional Personality Questionnaire scores in healthy subjects.
    Ruegg RG; Gilmore J; Ekstrom RD; Corrigan M; Knight B; Tancer M; Leatherman ME; Carson SW; Golden RN
    Biol Psychiatry; 1997 Dec; 42(12):1123-9. PubMed ID: 9426882
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Study of the clomipramine-morphine interaction in the forced swimming test in mice.
    Eschalier A; Fialip J; Varoquaux O; Makambila MC
    Psychopharmacology (Berl); 1987; 93(4):515-9. PubMed ID: 3124185
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clomipramine in obsessive-compulsive disorder. Further evidence for a serotonergic mechanism of action.
    Benkelfat C; Murphy DL; Zohar J; Hill JL; Grover G; Insel TR
    Arch Gen Psychiatry; 1989 Jan; 46(1):23-8. PubMed ID: 2910220
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clomipramine-induced sleep disturbance does not impair its prolactin-releasing action.
    Follenius M; Spiegel K; Gronfier C; Saini J; Brandenberger G
    J Endocrinol Invest; 1994 Jun; 17(6):417-23. PubMed ID: 7930386
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The cortical serotonin2 receptors studied with positron-emission tomography and [18F]-setoperone during depressive illness and antidepressant treatment with clomipramine.
    Attar-Lévy D; Martinot JL; Blin J; Dao-Castellana MH; Crouzel C; Mazoyer B; Poirier MF; Bourdel MC; Aymard N; Syrota A; Féline A
    Biol Psychiatry; 1999 Jan; 45(2):180-6. PubMed ID: 9951565
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Central 5-HT receptor hypersensitivity in migraine without aura.
    Cassidy EM; Tomkins E; Dinan T; Hardiman O; O'Keane V
    Cephalalgia; 2003 Feb; 23(1):29-34. PubMed ID: 12534577
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Allelic variants of the serotonin(2C) receptor and neuroendocrinological responses to the serotonin(2C) receptor agonist m-chlorophenylpiperazine in healthy male volunteers.
    Kühn KU; Quednow BB; Bagli M; Meyer K; Feuchtl A; Westheide J; Frahnert C; Maier W; Rao ML
    Pharmacopsychiatry; 2002 Nov; 35(6):226-30. PubMed ID: 12518270
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential effect of clomipramine treatment on m-chlorophenylpiperazine-induced increases in plasma prolactin and corticosterone in rats.
    Wozniak KM; Aulakh CS; Hill JL; Murphy DL
    Pharmacol Biochem Behav; 1989 May; 33(1):265-7. PubMed ID: 2780783
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Obsessive-compulsive disorder as a 5-HT subsystem-related behavioural disorder.
    Murphy DL; Zohar J; Benkelfat C; Pato MT; Pigott TA; Insel TR
    Br J Psychiatry Suppl; 1989 Dec; (8):15-24. PubMed ID: 2692636
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.